Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Jones

Showing results (1331-1340 of 3,162) with videos related to

Pageof 317
Sort By:
International Journal of Antimicrobial Agents|January 24, 2007
Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum StudyJames E Ross, Thomas R Fritsche, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|January 11, 2007
Activity of linezolid against 3,251 strains of uncommonly isolated gram-positive organisms: report from the SENTRY Antimicrobial Surveillance ProgramRonald N Jones, Matthew G Stilwell, Patricia A Hogan, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2006
Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocciRonald N Jones, Thomas R Fritsche, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|October 2, 2013
Daptomycin activity against uncommonly isolated streptococcal and other gram-positive species groupsHelio S Sader, Robert K Flamm, David J Farrell, et al.
Molecular and Cellular Biology|January 21, 2010
Identification and analysis of the interaction between Edc3 and Dcp2 in Saccharomyces cerevisiaeYuriko Harigaya, Brittnee N Jones, Denise Muhlrad, et al.
The Journal of Antimicrobial Chemotherapy|December 6, 2005
Oxazolidinone susceptibility patterns in 2004: report from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nationsRonald N Jones, James E Ross, Thomas R Fritsche, et al.
The Journal of Antimicrobial Chemotherapy|March 28, 2015
Activity of ceftaroline and comparator agents tested against Staphylococcus aureus from patients with bloodstream infections in US medical centres (2009-13)Helio S Sader, David J Farrell, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2015
Arbekacin activity against contemporary clinical bacteria isolated from patients hospitalized with pneumoniaHelio S Sader, Paul R Rhomberg, David J Farrell, et al.
Diagnostic Microbiology and Infectious Disease|April 6, 2007
Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniaeRonald N Jones, Helio S Sader, Matthew G Stilwell, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|January 18, 2007
Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004)Lalitagauri M Deshpande, Ronald N Jones, Thomas R Fritsche, et al.
Pageof 317

Showing results (1331-1340 of 3,162) with videos related to

Sort By:
Pageof 317
International Journal of Antimicrobial Agents|January 24, 2007
Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum StudyJames E Ross, Thomas R Fritsche, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|January 11, 2007
Activity of linezolid against 3,251 strains of uncommonly isolated gram-positive organisms: report from the SENTRY Antimicrobial Surveillance ProgramRonald N Jones, Matthew G Stilwell, Patricia A Hogan, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2006
Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocciRonald N Jones, Thomas R Fritsche, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|October 2, 2013
Daptomycin activity against uncommonly isolated streptococcal and other gram-positive species groupsHelio S Sader, Robert K Flamm, David J Farrell, et al.
Molecular and Cellular Biology|January 21, 2010
Identification and analysis of the interaction between Edc3 and Dcp2 in Saccharomyces cerevisiaeYuriko Harigaya, Brittnee N Jones, Denise Muhlrad, et al.
The Journal of Antimicrobial Chemotherapy|December 6, 2005
Oxazolidinone susceptibility patterns in 2004: report from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nationsRonald N Jones, James E Ross, Thomas R Fritsche, et al.
The Journal of Antimicrobial Chemotherapy|March 28, 2015
Activity of ceftaroline and comparator agents tested against Staphylococcus aureus from patients with bloodstream infections in US medical centres (2009-13)Helio S Sader, David J Farrell, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2015
Arbekacin activity against contemporary clinical bacteria isolated from patients hospitalized with pneumoniaHelio S Sader, Paul R Rhomberg, David J Farrell, et al.
Diagnostic Microbiology and Infectious Disease|April 6, 2007
Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniaeRonald N Jones, Helio S Sader, Matthew G Stilwell, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|January 18, 2007
Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004)Lalitagauri M Deshpande, Ronald N Jones, Thomas R Fritsche, et al.
Pageof 317